> Eli Lilly is down 5% because the market for their most profitable drug, a $125k/yr mAb IL-17 inhibitor, fell 5%. This is why Novartis, their major competitor with Cosentyx, is also down the same amount
> Not everything is about Twitter!
https://twitter.com/quantian1/status/1591149510168039426